Navigation
Content
Footer
US
Sandoz Site Directory
Search
Our Work
What We Do
Disease Areas
Quality Generics
Biosimilars
About Us
Who We Are
Where We Do Business
Corporate Responsibility
Doing Business Responsibly
For Novartis Investors
Contact Us
Patients & Customers
Report Side Effects
Product Safety Notices
Information for Customers
Products
News
US Press Releases & News
Media Contacts
Publications
Careers
Job Search
Working at Sandoz US
Diversity & Inclusion
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2017
March
Media Release
/
Mar 06, 2017
New data demonstrate Sandoz proposed biosimilar adalimumab has equivalent efficacy to reference medicine
Read More
January
Media Release
/
Jan 04, 2017
Sandoz launches generic version of Emend® capsules
Read More
2016
December
Media Release
/
Dec 15, 2016
Sandoz acquires consumer skin care brand AmLactin®
Read More
Media Release
/
Dec 07, 2016
Sandoz launches generic version of Latisse®
Read More
Media Release
/
Dec 05, 2016
New interim data demonstrate Sandoz proposed biosimilar rituximab has equivalent efficacy to reference product
Read More
November
Media Release
/
Nov 22, 2016
Sandoz to donate up to USD 10 million of high-quality generic medicines annually to Americares to increase access to medicines
Read More
August
Media Release
/
Aug 31, 2016
AirFluSal® Forspiro® showed superiority at 12 months over Seretide® Diskus®[1] in persistence to treatment
Read More
Media Release
/
Aug 30, 2016
FDA approves Sandoz Erelzi™ to treat multiple inflammatory diseases
Read More
Media Release
/
Aug 18, 2016
Launch of novel on-demand news service Transplant TODAY from TTS 2016 transplant congress
Read More
July
Media Release
/
Jul 21, 2016
Sandoz launches generic version of Crestor®
Read More
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
Pinterest
LinkedIn
Google +
Email
Jump to Comments
Print
Save
You are here
Home
›
News
›
